Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06030609
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2023-09-01
Brief Title:
The Comparison Between Ringer Lactate Solution and Normal Saline in Post-Operative Period of Kidney Transplantation
Sponsor:
King Chulalongkorn Memorial Hospital
Organization:
King Chulalongkorn Memorial Hospital
Study Overview
Official Title:
The Comparison Between Ringer Lactate Solution and Normal Saline in the First Week Post-Operative Period of Deceased Donor and Living Donor Kidney Transplantation
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RINNOR
Brief Summary:
This is a randomized controlled pragmatic clinical trial We aim to evaluate the effect of Ringer lactate solution RLS and normal saline solution NSS on the electrolyte abnormality of kidney transplant recipients KTR during the first post-operative week The problem with using NSS as a standard replacement fluid is the hyperchloremic metabolic acidosis which might compromise the kidney allograft function A total 60 KTR will be enrolled and randomized to receive either RLS or NSS The primary outcome is serum bicarbonate level at day 5 after transplantation Secondary outcomes include the serum potassium serum sodium serum chloride cytokine panel and the incidence of delayed graft function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None